Literature DB >> 24067471

Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese population.

X D Zhou1, L Yi, X J Guo, E Chen, H J Zou, L Jin, M D Mayes, S Assassi, J C Wang.   

Abstract

Specific human leukocyte antigen (HLA) DQB1 alleles confer strong susceptibility to systemic sclerosis (SSc). However, the frequencies of specific DQB1 alleles and their associations with SSc vary according to ethnicity and clinical features of SSc. The aim of this study was to profile DQB1 alleles in a Chinese population and to identify specific DQB1 alleles in association with SSc of Han Chinese. A cohort containing 213 patients with SSc and 239 gender-matched and unrelated controls was examined in the study. The HLA-DQB1 genotyping was performed with sequence-based typing (SBT) method. Exact p-values were obtained (Fisher's test) from 2x2 tables of allele counts or allele carriers and disease status. Seventeen DQB1 alleles were found in the cohort. DQB1*03:03 was the most common allele in this cohort. DQB1*05:01 was significantly increased in SSc, and was strongly associated with anti-centromere autoantibodies (ACA). Compared with SSc in other ethnic populations, SSc patients of Han Chinese are distinct in association with DQB1*06:11, common in association with DQB1*05:01, but lack association with DQB1*03:01. In addition, DQB1*06:01 appeared more common in ATA-positive Chinese SSc, and marginally associated with pulmonary fibrosis, and an increased frequency of DQB1*03:03 was observed in anti-U1RNP-positive Chinese SSc patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24067471      PMCID: PMC3887513          DOI: 10.1177/039463201302600318

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  14 in total

1.  HLA-DRB1 and DQB1 genes in Japanese patients with systemic sclerosis.

Authors:  S Akimoto; M Abe; O Ishikawa
Journal:  J Rheumatol       Date:  2000-12       Impact factor: 4.666

2.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

3.  HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.

Authors:  E Trachtenberg; M Vinson; E Hayes; Y-M Hsu; K Houtchens; H Erlich; W Klitz; Y Hsia; J Hollenbach
Journal:  Tissue Antigens       Date:  2007-09-27

4.  Association of HLA class II genes with systemic sclerosis in Spanish patients.

Authors:  Carmen P Simeón; Vicent Fonollosa; Carles Tolosa; Eduard Palou; Albert Selva; Roser Solans; Lluis Armadans; Estefania Moreno; Sara Marsal; Miquel Vilardell
Journal:  J Rheumatol       Date:  2009-11-02       Impact factor: 4.666

5.  Association of HLA class II genes with systemic sclerosis in Koreans.

Authors:  S H Kang; M H Park; E Y Song; S J Kang; E B Lee; Y W Song; F Takeuchi
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

6.  Clinical and serological features of systemic sclerosis in a Chinese cohort.

Authors:  Jiucun Wang; Shervin Assassi; Gang Guo; Wenzhen Tu; Wenyu Wu; Li Yang; Rong Xiao; Yongqiang Zhao; Haiyan Chu; Jie Liu; Yanyun Ma; Sarah J Kim; Li Jin; Maureen D Mayes; Hejian Zou; Xiaodong Zhou
Journal:  Clin Rheumatol       Date:  2012-12-28       Impact factor: 2.980

Review 7.  Systemic sclerosis: a prototypic multisystem fibrotic disorder.

Authors:  John Varga; David Abraham
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.

Authors:  Frank C Arnett; Pravitt Gourh; Sanjay Shete; Chul W Ahn; Robert E Honey; Sandeep K Agarwal; Filemon K Tan; Terry McNearney; Michael Fischbach; Marvin J Fritzler; Maureen D Mayes; John D Reveille
Journal:  Ann Rheum Dis       Date:  2009-07-12       Impact factor: 19.103

10.  The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).

Authors:  M Kuwana; J Kaburaki; Y Okano; H Inoko; K Tsuji
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more
  13 in total

Review 1.  Genetic predictors of systemic sclerosis-associated interstitial lung disease: a review of recent literature.

Authors:  Carmel J W Stock; Elisabetta A Renzoni
Journal:  Eur J Hum Genet       Date:  2018-02-23       Impact factor: 4.246

2.  Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.

Authors:  Xue Li; Yu-Quan Qian; Na Liu; Rong Mu; Yu Zuo; Guo-Chun Wang; Yuan Jia; Zhan-Guo Li
Journal:  Clin Rheumatol       Date:  2018-09-18       Impact factor: 2.980

3.  HLA Class I and II Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients.

Authors:  Tatiana S Rodriguez-Reyna; Pamela Mercado-Velázquez; Neng Yu; Sharon Alosco; Marina Ohashi; Tatiana Lebedeva; Alfredo Cruz-Lagunas; Carlos Núñez-Álvarez; Javier Cabiedes-Contreras; Gilberto Vargas-Alarcón; Julio Granados; Joaquin Zúñiga; Edmond Yunis
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

Review 4.  Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight).

Authors:  Hiroshi Furukawa; Shomi Oka; Kota Shimada; Naoyuki Tsuchiya; Shigeto Tohma
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-04-29

5.  Possible single-nucleotide polymorphism loci associated with systemic sclerosis susceptibility: a genetic association study in a Chinese Han population.

Authors:  Chang Shu; Wei Du; Xiaofei Mao; Yun Li; Qin Zhu; Wei Wang; Nan Wu; Xuming Mao; Hongzhong Jin; Qiuning Sun
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

6.  Association of the HLA-DRB1 with scleroderma in Chinese population.

Authors:  Dongyi He; Jiucun Wang; Lin Yi; Xinjian Guo; Shicheng Guo; Gang Guo; Wenzhen Tu; Wenyu Wu; Li Yang; Rong Xiao; Yuan Li; Haiyan Chu; Syeling Lai; Li Jin; Hejian Zou; John D Reveille; Shervin Assassi; Maureen D Mayes; Xiaodong Zhou
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

7.  Systemic Sclerosis is a Complex Disease Associated Mainly with Immune Regulatory and Inflammatory Genes.

Authors:  Jingxiao Jin; Chou Chou; Maria Lima; Danielle Zhou; Xiaodong Zhou
Journal:  Open Rheumatol J       Date:  2014-09-29

8.  Lack of Association of the CD247 SNP rs2056626 with Systemic Sclerosis in Han Chinese.

Authors:  Jiucun Wang; Lin Yi; Xinjian Guo; Dongyi He; Hongyi Li; Gang Guo; Yi Wang; Hejian Zou; Yuanhui Gu; Wenzhen Tu; Wenyu Wu; Li Yang; Rong Xiao; Syeling Lai; Shervin Assassi; Maureen D Mayes; Xiaodong Zhou
Journal:  Open Rheumatol J       Date:  2014-10-02

9.  Association of HLA-DPB1 with scleroderma and its clinical features in Chinese population.

Authors:  Jiucun Wang; Xinjian Guo; Lin Yi; Gang Guo; Wenzhen Tu; Wenyu Wu; Li Yang; Rong Xiao; Yuan Li; Haiyan Chu; Dongyi He; Li Jin; Maureen D Mayes; Hejian Zou; Xiaodong Zhou
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

10.  Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01.

Authors:  Hiroshi Furukawa; Shomi Oka; Aya Kawasaki; Kota Shimada; Shoji Sugii; Takashi Matsushita; Atsushi Hashimoto; Akiko Komiya; Naoshi Fukui; Kouji Kobayashi; Atsumu Osada; Atsushi Ihata; Yuya Kondo; Tatsuo Nagai; Keigo Setoguchi; Akiko Okamoto; Akira Okamoto; Noriyuki Chiba; Eiichi Suematsu; Hajime Kono; Masao Katayama; Shunsei Hirohata; Takayuki Sumida; Kiyoshi Migita; Minoru Hasegawa; Manabu Fujimoto; Shinichi Sato; Shouhei Nagaoka; Kazuhiko Takehara; Shigeto Tohma; Naoyuki Tsuchiya
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.